CareCloud Reports Third Quarter 2025 Results
CareCloud (Nasdaq: CCLD) reported third quarter 2025 results and raised full-year revenue guidance to $117–$119 million (previously $111–$114M). Q3 revenue was $31.1 million, up 9% year-over-year, marking six consecutive quarters of positive GAAP net income. Q3 GAAP net income was $3.1 million and adjusted EBITDA was $7.7 million (up 13% YoY). Nine-month revenue was $86.1 million (+4% YoY) and YTD adjusted EBITDA was $19.9 million. The company completed the Medsphere acquisition for a total purchase price of $16.5 million, reduced line-of-credit borrowings to $4.9 million, and launched an AI Center of Excellence to scale generative AI initiatives.
- Revenue +9% Q3 to $31.1 million
- Raised FY2025 revenue guidance to $117–$119 million
- Adjusted EBITDA +13% Q3 to $7.7 million
- Six consecutive quarters of GAAP net income
- Medsphere acquisition closed for $16.5 million
- Line-of-credit borrowings remain $4.9 million after acquisition
- Revenue growth only +4% YTD through nine months ($86.1M)
Insights
CareCloud raised full‑year revenue guidance, reported sequential profitable growth, and closed a strategic acquisition while accelerating AI efforts.
CareCloud shows clear revenue momentum: quarterly revenue of
The business case rests on three explicit drivers: recurring revenue growth, acquisition contributions (including the completed Medsphere purchase and four acquisitions year‑to‑date), and an active AI Center of Excellence. Risks called out in the release are integration and execution challenges; management itself highlights customer migrations, cost control, and systems integration as potential headwinds. CareCloud also reduced its line‑of‑credit borrowing to
Watch the integration metrics and short‑term milestones: verify contribution from recent acquisitions to revenue and EBITDA, track quarterly retention and cross‑sell metrics, and confirm AI deployment timelines over the next
Raises Revenue Guidance, Completes Medsphere Acquisition and Accelerates AI Initiative
SOMERSET, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO), a leader in healthcare technology and generative AI solutions, today announced strong financial results for the quarter ended September 30, 2025, and is increasing its full-year 2025 revenue guidance to
2025 Financial Highlights
| Three Months Ended September 30, | |||||||||||
| 2025 | 2024 | Change | |||||||||
| Revenue | $ | 31.1 million | $ | 28.5 million | 9 | % | |||||
| GAAP Net Income | $ | 3.1 million | $ | 3.1 million | Sustained profitability | ||||||
| GAAP EPS | $ | 0.04 | $ | (0.04 | ) | Improved by | |||||
| Adjusted Net Income | $ | 4.4 million | $ | 3.5 million | 27 | % | |||||
| Adjusted EBITDA | $ | 7.7 million | $ | 6.8 million | 13 | % | |||||
| Nine Months Ended September 30, | |||||||||||
| 2025 | 2024 | Change | |||||||||
| Revenue | $ | 86.1 million | $ | 82.6 million | 4 | % | |||||
| GAAP Net Income | $ | 7.9 million | $ | 4.6 million | 74 | % | |||||
| GAAP EPS | $ | 0.07 | $ | (0.28 | ) | Improved by | |||||
| Adjusted Net Income | $ | 10.0 million | $ | 6.6 million | 50 | % | |||||
| Adjusted EBITDA | $ | 19.9 million | $ | 16.9 million | 17 | % | |||||
Recent Strategic Updates
- Acquisitions: Completed four strategic acquisitions so far this year, with two since our last earnings release
- AI Center of Excellence: Now live and scaling, with dedicated teams driving product innovation
Management Commentary
“We are excited to raise our full-year 2025 revenue guidance, marking another strong quarter of execution and growth for CareCloud,” said Stephen Snyder, Co-Chief Executive Officer of CareCloud. “This performance extends our record of profitable expansion and reflects the positive impact of the Medsphere and Map App acquisitions, broadening our reach within the hospital market across both ambulatory and inpatient care settings.”
“Our recent acquisitions and AI initiatives are working hand in hand to create meaningful value for our clients and shareholders,” said A. Hadi Chaudhry, Co-Chief Executive Officer of CareCloud. “By infusing AI into acquired platforms, we’re enhancing performance, driving efficiency, and opening new cross-sell and up-sell opportunities that strengthen CareCloud’s long-term growth trajectory.”
“This quarter marks a strategic milestone for CareCloud, with a combination of significant revenue growth along with GAAP profitability and strong cash flow from operations,” said Norman Roth, Interim CFO and Corporate Controller of CareCloud. “This is our sixth consecutive quarter of positive GAAP net income and it is coupled with an increase in year-to-date revenue and adjusted EBITDA year over year. We have reduced our line of credit borrowing to
2025 Guidance: Poised for Growth
CareCloud is increasing its full-year 2025 revenue guidance for the second time this year from
| For the Fiscal Year Ending December 31, 2025 Forward-Looking Guidance | ||||
| Revenue | ||||
| Adjusted EBITDA | ||||
| Net Income Per Share (EPS) | ||||
The Company is increasing its full year 2025 revenue guidance to approximately
Adjusted EBITDA is expected to be
Conference Call Information
CareCloud management will host a conference call today at 8:30 a.m. Eastern Time to discuss the nine months 2025 results. The live webcast of the conference call and related presentation slides can be accessed at ir.carecloud.com/events. An audio-only option is available by dialing 201-389-0920 and referencing “CareCloud, Inc. Third Quarter 2025 Results Conference Call.” Investors who opt for audio-only will need to download the related slides at ir.carecloud.com/events.
A replay of the conference call and related presentation slides will be available approximately three hours after conclusion of the call at the same link. An audio-only option can also be accessed by dialing 412-317-6671 and providing the access code 13756158.
Use of Non-GAAP Financial Measures
In our earnings releases, prepared remarks, conference calls, slide presentations, and webcasts, we use and discuss non-GAAP financial measures, as defined by SEC Regulation G. The GAAP financial measure most directly comparable to each non-GAAP financial measure used or discussed, and a reconciliation of the differences between each non-GAAP financial measure and the comparable GAAP financial measure, are included in this press release after the condensed consolidated financial statements. Our earnings press releases containing such non-GAAP reconciliations can be found in the Investor Relations section of our web site at ir.carecloud.com.
Forward-Looking Statements
This press release contains various forward-looking statements within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements relate to anticipated future events, future results of operations or future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may,” “might,” “will,” “shall,” “should,” “could,” “intends,” “expects,” “plans,” “goals,” “projects,” “anticipates,” “believes,” “seeks,” “estimates,” “forecasts,” “predicts,” “possible,” “potential,” “target,” or “continue” or the negative of these terms or other comparable terminology.
Our operations involve risks and uncertainties, many of which are outside our control, and any one of which, or a combination of which, could materially affect our results of operations and whether the forward-looking statements ultimately prove to be correct. Forward-looking statements in this press release include, without limitation, statements reflecting management's expectations for future financial performance and operating expenditures, expected growth, profitability and business outlook, the impact of pandemics on our financial performance and business activities, and the expected results from the integration of our acquisitions.
These forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are only predictions, are uncertain and involve substantial known and unknown risks, uncertainties and other factors which may cause our (or our industry’s) actual results, levels of activity or performance to be materially different from any future results, levels of activity or performance expressed or implied by these forward-looking statements. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all of the risks and uncertainties that could have an impact on the forward-looking statements, including without limitation, risks and uncertainties relating to the Company’s ability to manage growth, migrate newly acquired customers and retain new and existing customers, maintain cost-effective global operations, increase operational efficiency and reduce operating costs, predict and properly adjust to changes in reimbursement and other industry regulations and trends, retain the services of key personnel, develop new technologies, upgrade and adapt legacy and acquired technologies to work with evolving industry standards, compete with other companies’ products and services competitive with ours, manage and keep our information systems secure and other important risks and uncertainties referenced and discussed under the heading titled “Risk Factors” in the Company’s filings with the Securities and Exchange Commission.
The statements in this press release are made as of the date of this press release, even if subsequently made available by the Company on its website or otherwise. The Company does not assume any obligations to update the forward-looking statements provided to reflect events that occur or circumstances that exist after the date on which they were made.
About CareCloud
CareCloud brings disciplined innovation and generative AI solutions to the business of healthcare. Our suite of technology-enabled solutions helps clients increase financial and operational performance, streamline clinical workflows and improve the patient experience. More than 45,000 providers count on CareCloud to help them improve patient care while reducing administrative burdens and operating costs. Learn more about our products and services, including revenue cycle management (RCM), practice management (PM), electronic health records (EHR), artificial intelligence (AI), business intelligence (BI), patient experience management (PXM) and digital health, at carecloud.com.
Follow CareCloud on LinkedIn, X and Facebook.
For additional information, please visit our website at carecloud.com. To listen to video presentations by CareCloud’s management team, read recent press releases and view the latest investor presentation, please visit ir.carecloud.com.
SOURCE CareCloud
Company Contact:
Norman Roth
Interim Chief Financial Officer and Corporate Controller
CareCloud, Inc.
nroth@carecloud.com
Investor Contact:
Stephen Snyder
Co-Chief Executive Officer
CareCloud, Inc.
ir@carecloud.com
CARECLOUD, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
($ in thousands, except share and per share amounts)
| September 30, | December 31, | |||||||
| 2025 | 2024 | |||||||
| (Unaudited) | ||||||||
| ASSETS | ||||||||
| Current assets: | ||||||||
| Cash | $ | 4,258 | $ | 5,145 | ||||
| Restricted cash | 815 | - | ||||||
| Accounts receivable - net | 15,319 | 12,774 | ||||||
| Contract asset | 3,957 | 4,334 | ||||||
| Inventory | 605 | 574 | ||||||
| Current assets - related party | 16 | 16 | ||||||
| Prepaid expenses and other current assets | 4,294 | 1,957 | ||||||
| Total current assets | 29,264 | 24,800 | ||||||
| Property and equipment - net | 6,314 | 5,290 | ||||||
| Operating lease right-of-use assets | 2,781 | 3,133 | ||||||
| Intangible assets - net | 21,257 | 18,698 | ||||||
| Goodwill | 30,411 | 19,186 | ||||||
| Other assets | 549 | 507 | ||||||
| TOTAL ASSETS | $ | 90,576 | $ | 71,614 | ||||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | ||||||||
| Current liabilities: | ||||||||
| Accounts payable | $ | 6,693 | $ | 4,565 | ||||
| Accrued compensation | 3,830 | 1,817 | ||||||
| Accrued expenses | 5,671 | 4,951 | ||||||
| Operating lease liability (current portion) | 1,105 | 1,287 | ||||||
| Deferred revenue (current portion) | 4,266 | 1,212 | ||||||
| Notes payable (current portion) | 149 | 310 | ||||||
| Contingent consideration (current portion) | 777 | - | ||||||
| Dividend payable | 714 | 5,438 | ||||||
| Total current liabilities | 23,205 | 19,580 | ||||||
| Notes payable | 230 | 26 | ||||||
| Borrowings under line of credit | 6,500 | - | ||||||
| Contingent consideration | 426 | - | ||||||
| Operating lease liability | 1,682 | 1,847 | ||||||
| Deferred revenue | 729 | 387 | ||||||
| Total liabilities | 32,772 | 21,840 | ||||||
| COMMITMENTS AND CONTINGENCIES | ||||||||
| SHAREHOLDERS’ EQUITY: | ||||||||
| Preferred stock, | 2 | 6 | ||||||
| Common stock, | 43 | 17 | ||||||
| Additional paid-in capital | 121,218 | 121,046 | ||||||
| Accumulated deficit | (58,720 | ) | (66,630 | ) | ||||
| Accumulated other comprehensive loss | (4,077 | ) | (4,003 | ) | ||||
| Less: 740,799 common shares held in treasury, at cost at September 30, 2025 and December 31, 2024 | (662 | ) | (662 | ) | ||||
| Total shareholders’ equity | 57,804 | 49,774 | ||||||
| TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | $ | 90,576 | $ | 71,614 | ||||
CARECLOUD, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
($ in thousands, except share and per share amounts)
| Three Months Ended | Nine Months Ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| NET REVENUE | $ | 31,067 | $ | 28,546 | $ | 86,076 | $ | 82,598 | ||||||||
| OPERATING EXPENSES: | ||||||||||||||||
| Direct operating costs | 16,224 | 15,420 | 46,168 | 45,839 | ||||||||||||
| Selling and marketing | 1,123 | 1,375 | 3,372 | 4,809 | ||||||||||||
| General and administrative | 4,887 | 4,378 | 13,577 | 12,127 | ||||||||||||
| Research and development | 1,584 | 800 | 3,839 | 2,768 | ||||||||||||
| Depreciation and amortization | 4,022 | 3,241 | 10,741 | 10,885 | ||||||||||||
| Restructuring costs | 17 | 67 | 154 | 505 | ||||||||||||
| Total operating expenses | 27,857 | 25,281 | 77,851 | 76,933 | ||||||||||||
| OPERATING INCOME | 3,210 | 3,265 | 8,225 | 5,665 | ||||||||||||
| OTHER: | ||||||||||||||||
| Interest income | 95 | 17 | 188 | 68 | ||||||||||||
| Interest expense | (147 | ) | (179 | ) | (273 | ) | (832 | ) | ||||||||
| Other (expense) income - net | (55 | ) | 60 | (104 | ) | (227 | ) | |||||||||
| INCOME BEFORE PROVISION FOR INCOME TAXES | 3,103 | 3,163 | 8,036 | 4,674 | ||||||||||||
| Income tax provision | 43 | 41 | 126 | 119 | ||||||||||||
| NET INCOME | $ | 3,060 | $ | 3,122 | $ | 7,910 | $ | 4,555 | ||||||||
| Preferred stock dividend | 1,365 | 3,789 | 5,541 | 9,024 | ||||||||||||
| NET INCOME (LOSS) ATTRIBUTABLE TO COMMON SHAREHOLDERS | $ | 1,695 | $ | (667 | ) | $ | 2,369 | $ | (4,469 | ) | ||||||
| Net income (loss) per common share: basic and diluted | $ | 0.04 | $ | (0.04 | ) | $ | 0.07 | $ | (0.28 | ) | ||||||
| Weighted-average common shares used to compute basic and diluted loss per share | 42,368,914 | 16,195,363 | 36,236,128 | 16,114,330 | ||||||||||||
CARECLOUD, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2025 AND 2024
($ in thousands)
| 2025 | 2024 | |||||||
| OPERATING ACTIVITIES: | ||||||||
| Net income | $ | 7,910 | $ | 4,555 | ||||
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||
| Depreciation and amortization | 10,936 | 11,138 | ||||||
| Lease amortization | 1,319 | 1,502 | ||||||
| Provision for expected credit losses | 343 | 284 | ||||||
| Foreign exchange loss (gain) | 60 | (114 | ) | |||||
| Interest accretion | 326 | 465 | ||||||
| Stock-based compensation expense (benefit) | 307 | (191 | ) | |||||
| Changes in operating assets and liabilities: | ||||||||
| Accounts receivable | (796 | ) | (388 | ) | ||||
| Contract asset | 461 | 477 | ||||||
| Inventory | (31 | ) | (49 | ) | ||||
| Other assets | (2,581 | ) | (63 | ) | ||||
| Accounts payable and other liabilities | 2,124 | (2,206 | ) | |||||
| Deferred revenue | (492 | ) | 3 | |||||
| Net cash provided by operating activities | 19,886 | 15,413 | ||||||
| INVESTING ACTIVITIES: | ||||||||
| Purchases of property and equipment | (2,655 | ) | (759 | ) | ||||
| Capitalized software and other intangible assets | (2,505 | ) | (4,385 | ) | ||||
| Payments for acquisitions | (16,040 | ) | - | |||||
| Net cash used in investing activities | (21,200 | ) | (5,144 | ) | ||||
| FINANCING ACTIVITIES: | ||||||||
| Preferred stock dividends paid | (4,821 | ) | - | |||||
| Payment of contingent obligations | (53 | ) | - | |||||
| Payment of tax withholding obligations on stock issued to employees | (22 | ) | (200 | ) | ||||
| Repayments of notes payable | (378 | ) | (478 | ) | ||||
| Proceeds from line of credit | 8,343 | - | ||||||
| Repayment of line of credit | (1,843 | ) | (10,000 | ) | ||||
| Net cash provided by (used in) financing activities | 1,226 | (10,678 | ) | |||||
| EFFECT OF EXCHANGE RATE CHANGES ON CASH | 16 | (140 | ) | |||||
| NET DECREASE IN CASH | (72 | ) | (549 | ) | ||||
| CASH - Beginning of the period | 5,145 | 3,331 | ||||||
| CASH AND RESTRICTED CASH - End of the period | $ | 5,073 | $ | 2,782 | ||||
| SUPPLEMENTAL NONCASH INVESTING AND FINANCING ACTIVITIES: | ||||||||
| Conversion of preferred stock and accrued dividends to common stock | $ | 2,435 | $ | - | ||||
| Dividends declared, not paid | $ | 714 | $ | 5 | ||||
| Purchase of prepaid insurance with assumption of note | $ | - | $ | 685 | ||||
| Reclass of deposits for property and equipment placed in service | $ | - | $ | 296 | ||||
| SUPPLEMENTAL INFORMATION - Cash paid during the period for: | ||||||||
| Income taxes | $ | 172 | $ | 145 | ||||
| Interest | $ | 64 | $ | 642 | ||||
RECONCILIATION OF NON-GAAP FINANCIAL MEASURES
TO COMPARABLE GAAP MEASURES (UNAUDITED)
The following is a reconciliation of the non-GAAP financial measures used by us to describe our financial results determined in accordance with accounting principles generally accepted in the United States of America (“GAAP”). An explanation of these measures is also included below under the heading “Explanation of Non-GAAP Financial Measures.”
While management believes that these non-GAAP financial measures provide useful supplemental information to investors regarding the underlying performance of our business operations, investors are reminded to consider these non-GAAP measures in addition to, and not as a substitute for, financial performance measures prepared in accordance with GAAP. In addition, it should be noted that these non-GAAP financial measures may be different from non-GAAP measures used by other companies, and management may utilize other measures to illustrate performance in the future. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP.
Adjusted EBITDA to GAAP Net Income
Set forth below is a reconciliation of our “adjusted EBITDA” to our GAAP net income.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| ($ in thousands) | ||||||||||||||||
| Net revenue | $ | 31,067 | $ | 28,546 | $ | 86,076 | $ | 82,598 | ||||||||
| GAAP net income | 3,060 | 3,122 | 7,910 | 4,555 | ||||||||||||
| Provision for income taxes | 43 | 41 | 126 | 119 | ||||||||||||
| Net interest expense | 52 | 162 | 85 | 764 | ||||||||||||
| Foreign exchange loss (gain) / other expense | 60 | (57 | ) | 120 | 244 | |||||||||||
| Stock-based compensation expense (benefit) | 88 | 252 | 307 | (191 | ) | |||||||||||
| Depreciation and amortization | 4,022 | 3,241 | 10,741 | 10,885 | ||||||||||||
| Transaction and integration costs | 391 | 12 | 414 | 35 | ||||||||||||
| Restructuring costs | 17 | 67 | 154 | 505 | ||||||||||||
| Adjusted EBITDA | $ | 7,733 | $ | 6,840 | $ | 19,857 | $ | 16,916 | ||||||||
Non-GAAP Adjusted Operating Income to GAAP Operating Income
Set forth below is a reconciliation of our non-GAAP “adjusted operating income” and non-GAAP “adjusted operating margin” to our GAAP operating income and GAAP operating margin.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| ($ in thousands) | ||||||||||||||||
| Net revenue | $ | 31,067 | $ | 28,546 | $ | 86,076 | $ | 82,598 | ||||||||
| GAAP net income | 3,060 | 3,122 | 7,910 | 4,555 | ||||||||||||
| Provision for income taxes | 43 | 41 | 126 | 119 | ||||||||||||
| Net interest expense | 52 | 162 | 85 | 764 | ||||||||||||
| Other expense (income) - net | 55 | (60 | ) | 104 | 227 | |||||||||||
| GAAP operating income | 3,210 | 3,265 | 8,225 | 5,665 | ||||||||||||
| GAAP operating margin | 10.3 | % | 11.4 | % | 9.6 | % | 6.9 | % | ||||||||
| Stock-based compensation expense (benefit) | 88 | 252 | 307 | (191 | ) | |||||||||||
| Amortization of purchased intangible assets | 794 | 75 | 1,076 | 1,501 | ||||||||||||
| Transaction and integration costs | 391 | 12 | 414 | 35 | ||||||||||||
| Restructuring costs | 17 | 67 | 154 | 505 | ||||||||||||
| Non-GAAP adjusted operating income | $ | 4,500 | $ | 3,671 | $ | 10,176 | $ | 7,515 | ||||||||
| Non-GAAP adjusted operating margin | 14.5 | % | 12.9 | % | 11.8 | % | 9.1 | % | ||||||||
Non-GAAP Adjusted Net Income to GAAP Net Income
Set forth below is a reconciliation of our non-GAAP “adjusted net income” and non-GAAP “adjusted net income per share” to our GAAP net income and GAAP net income per share.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| ($ in thousands) | ||||||||||||||||
| GAAP net income | $ | 3,060 | $ | 3,122 | $ | 7,910 | $ | 4,555 | ||||||||
| Foreign exchange loss (gain) / other expense | 60 | (57 | ) | 120 | 244 | |||||||||||
| Stock-based compensation expense (benefit) | 88 | 252 | 307 | (191 | ) | |||||||||||
| Amortization of purchased intangible assets | 794 | 75 | 1,076 | 1,501 | ||||||||||||
| Transaction and integration costs | 391 | 12 | 414 | 35 | ||||||||||||
| Restructuring costs | 17 | 67 | 154 | 505 | ||||||||||||
| Non-GAAP adjusted net income | $ | 4,410 | $ | 3,471 | $ | 9,981 | $ | 6,649 | ||||||||
For purposes of determining non-GAAP adjusted net income per share, we used the number of common shares outstanding as of September 30, 2025 and 2024.
| Three Months Ended September 30, | Nine Months Ended September 30, | |||||||||||||||
| 2025 | 2024 | 2025 | 2024 | |||||||||||||
| GAAP net income (loss) attributable to common shareholders, per share | $ | 0.04 | $ | (0.04 | ) | $ | 0.07 | $ | (0.28 | ) | ||||||
| Impact of preferred stock dividend | 0.03 | 0.23 | 0.12 | 0.56 | ||||||||||||
| Net income per end-of-period share | 0.07 | 0.19 | 0.19 | 0.28 | ||||||||||||
| Foreign exchange loss (gain) / other expense | 0.00 | 0.00 | 0.00 | 0.02 | ||||||||||||
| Stock-based compensation expense (benefit) | 0.00 | 0.02 | 0.01 | (0.01 | ) | |||||||||||
| Amortization of purchased intangible assets | 0.02 | 0.00 | 0.03 | 0.09 | ||||||||||||
| Transaction and integration costs | 0.01 | 0.00 | 0.01 | 0.00 | ||||||||||||
| Restructuring costs | 0.00 | 0.00 | 0.00 | 0.03 | ||||||||||||
| Non-GAAP adjusted earnings per share | $ | 0.10 | $ | 0.21 | $ | 0.24 | $ | 0.41 | ||||||||
| End-of-period common shares | 42,397,039 | 16,221,820 | 42,397,039 | 16,221,820 | ||||||||||||
Explanation of Non-GAAP Financial Measures
We report our financial results in accordance with accounting principles generally accepted in the United States of America, or GAAP. However, management believes that, in order to properly understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures in accordance with GAAP. These items result from facts and circumstances that vary in frequency and impact on continuing operations. Management also uses results of operations before such items to evaluate the operating performance of CareCloud and compare it against past periods, make operating decisions, and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management’s ability to make useful forecasts. Management believes that these non-GAAP financial measures provide additional means of evaluating period-over-period operating performance. In addition, management understands that some investors and financial analysts find this information helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.
Management uses adjusted EBITDA, adjusted operating income, adjusted operating margin, and non-GAAP adjusted net income to provide an understanding of aspects of operating results before the impact of investing and financing charges and income taxes. Adjusted EBITDA may be useful to an investor in evaluating our operating performance and liquidity because this measure excludes non-cash expenses as well as expenses pertaining to investing or financing transactions. Management defines “adjusted EBITDA” as the sum of GAAP net income (loss) before provision for (benefit from) income taxes, net interest expense, other (income) expense, stock-based compensation expense, depreciation and amortization, integration costs, transaction costs, impairment charges and changes in contingent consideration.
Management defines “non-GAAP adjusted operating income” as the sum of GAAP operating income (loss) before stock-based compensation expense, amortization of purchased intangible assets, integration costs, transaction costs, impairment charges and changes in contingent consideration, and “non-GAAP adjusted operating margin” as non-GAAP adjusted operating income divided by net revenue.
Management defines “non-GAAP adjusted net income” as the sum of GAAP net income (loss) before stock-based compensation expense, amortization of purchased intangible assets, other (income) expense, integration costs, transaction costs, impairment charges, changes in contingent consideration, any tax impact related to these preceding items and income tax expense related to goodwill, and “non-GAAP adjusted net income per share” as non-GAAP adjusted net income divided by common shares outstanding at the end of the period, including the shares which were issued but are subject to forfeiture and considered contingent consideration.
Management considers all of these non-GAAP financial measures to be important indicators of our operational strength and performance of our business and a good measure of our historical operating trends, in particular the extent to which ongoing operations impact our overall financial performance.
In addition to items routinely excluded from non-GAAP EBITDA, management excludes or adjusts each of the items identified below from the applicable non-GAAP financial measure referenced above for the reasons set forth with respect to that excluded item:
Foreign exchange loss/other expense. Other expense is excluded because foreign currency gains and losses and other non-operating expenses are expenditures that management does not consider part of ongoing operating results when assessing the performance of our business, and also because the total amount of the expense is partially outside of our control. Foreign currency gains and losses are based on global market factors which are unrelated to our performance during the period in which the gains and losses are recorded.
Stock-based compensation expense (benefit). Stock-based compensation expense (benefit) is excluded because this is primarily a non-cash expenditure that management does not consider part of ongoing operating results when assessing the performance of our business, and also because the total amount of the expenditure is partially outside of our control because it is based on factors such as stock price, volatility, and interest rates, which may be unrelated to our performance during the period in which the expenses are incurred. Stock-based compensation expense includes cash-settled awards based on changes in the stock price.
Amortization of purchased intangible assets. Purchased intangible assets are amortized over their estimated useful lives and generally cannot be changed or influenced by management after the acquisition. Accordingly, this item is not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are recorded.
Transaction costs. Transaction costs are upfront costs related to acquisitions and related transactions, such as brokerage fees, pre-acquisition accounting costs and legal fees, and other upfront costs related to specific transactions. Management believes that such expenses do not have a direct correlation to future business operations, and therefore, these costs are not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
Integration costs. Integration costs are severance payments for certain employees relating to our acquisitions and exit costs related to terminating leases and other contractual agreements. Accordingly, management believes that such expenses do not have a direct correlation to future business operations, and therefore, these costs are not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
Restructuring costs. Restructuring costs primarily consist of severance and separation costs associated with the optimization of the Company’s operations and profitability improvements. Management believes that such expenses do not have a direct correlation to future business operations, and therefore, these costs are not considered by management in making operating decisions. Management does not believe such charges accurately reflect the performance of our ongoing operations for the period in which such charges are incurred.
FAQ
What did CareCloud (CCLD) report for Q3 2025 revenue and net income?
How did CareCloud change its full-year 2025 guidance on November 6, 2025?
What was the financial impact of the Medsphere acquisition for CareCloud (CCLD)?
What is CareCloud’s adjusted EBITDA performance through nine months 2025?
How much did CareCloud reduce its line-of-credit borrowing after the acquisition?
What strategic initiatives did CareCloud highlight in the November 6, 2025 release?
